Found: 7
Select item for more details and to access through your institution.
Author Correction: Development of an anti-tauopathy mucosal vaccine specifically targeting pathologic conformers.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Development of an anti-tauopathy mucosal vaccine specifically targeting pathologic conformers.
- Published in:
- NPJ Vaccines, 2024, v. 9, n. 1, p. 1, doi. 10.1038/s41541-024-00910-3
- By:
- Publication type:
- Article
Deglycosylation of eukaryotic-expressed flagellin restores adjuvanticity.
- Published in:
- NPJ Vaccines, 2023, v. 8, n. 1, p. 1, doi. 10.1038/s41541-023-00738-3
- By:
- Publication type:
- Article
Deimmunization of flagellin for repeated administration as a vaccine adjuvant.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00379-4
- By:
- Publication type:
- Article
Combination of Photodynamic Therapy and a Flagellin-Adjuvanted Cancer Vaccine Potentiated the Anti-PD-1-Mediated Melanoma Suppression.
- Published in:
- Cells (2073-4409), 2020, v. 9, n. 11, p. 2432, doi. 10.3390/cells9112432
- By:
- Publication type:
- Article
A stealth adhesion factor contributes to Vibrio vulnificus pathogenicity: Flp pili play roles in host invasion, survival in the blood stream and resistance to complement activation.
- Published in:
- PLoS Pathogens, 2019, v. 15, n. 8, p. 1, doi. 10.1371/journal.ppat.1007767
- By:
- Publication type:
- Article
Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB.
- Published in:
- 2016
- By:
- Publication type:
- journal article